Total planned funding: $145,141,040
Allocations
Countries/Regions
Ukraine | $145,141,040 |
Organizational Types
Unknown | $38,572,861 |
Private Contractor | $33,640,981 |
NGO | $28,524,514 |
Own Agency | $17,979,970 |
Multi-lateral Agency | $12,275,607 |
University | $6,277,000 |
Implementing Agency | $4,272,000 |
Other USG Agency | $3,348,107 |
Host Country Government Agency | $250,000 |
Program Areas
Governance and Systems | $63,881,704 |
Treatment | $25,102,309 |
Prevention | $19,965,750 |
Management and Operations | $12,750,668 |
Care | $11,996,123 |
Testing | $11,444,486 |
Budget Codes
OHSS: Health Systems Strengthening | $33,920,837 |
HVSI: Strategic Information | $18,351,116 |
HTXS: Treatment: Adult Treatment | $13,671,195 |
HVMS: Management and Operations | $12,750,668 |
HLAB: Laboratory Infrastructure | $11,609,751 |
HVCT: Testing: HIV Testing and Counseling | $11,444,486 |
HTXD: Treatment: ARV Drugs | $11,431,114 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $9,831,195 |
HVTB: Care: TB/HIV | $7,769,895 |
HVOP: Sexual Prevention: Other Sexual Prevention | $7,263,089 |
HKID: Care: Orphans and Vulnerable Children | $2,305,193 |
HMBL: Biomedical Prevention: Blood Safety | $2,083,319 |
HBHC: Care: Adult Care and Support | $1,921,035 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HMIN: Biomedical Prevention: Injection Safety | $250,000 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $244,790 |
Top Partner Programs
Not Available:
$38,572,861
Countries/Regions
Chemonics International:
$17,819,470
Countries/Regions
USG Aggregated Agencies:
$15,664,383
Countries/Regions
Deloitte Consulting Limited:
$10,671,511
Countries/Regions